Akut Böbrek Hasarında Mortalitede Öncül Faktörler

Amaç: Prokalsitonin (PCT), C-Reaktif Protein (CRP), serum amiloid A (SAA), albümin ve serum kolesterol değerleri enflamasyon, enfeksiyon ve malnütrisyonun erken belirteçlerindendir. Akut böbrek hasarının (ABH) gelişiminde enfeksiyon, oral alım bozukluğu, dehidratasyon ve malnütrisyon önemli yer tutmaktadır. Bu etkenlerin erken saptanması tedavide önem arz etmektedir.Gereç ve Yöntem: Ocak 2013-2014 tarihleri arasında Nefroloji Kliniğimizde takip edilen 182 hastaya RIFLE (Risk, injury, failure, loss, end stage renal failure) ve AKIN (acute kidney injury network) kriterlerine göre ABH tanısı konmuştur. Hastalar nutrisyonel ve enflamatuar belirteç- lere göre sağlıklı kontrol grubuyla (52 hasta) kıyaslanmış- tır.Bulgular: ABH da albümin, CRP, prokalsitonin ve SAA değerleri hasta grubu lehine, sağlıklı kontrol grubuyla karşılaştırıldığında anlamlı bulunmuştur (p < 0,001 ve p = 0,002) Yine lökosit, kolesterol, LDL kolesterol, trigliserit değerleri karşılaştırıldığında ölen ABH hastalarında yüksek saptanmıştır (p = 0,016, p = 0,032, p = 0,03 ve p = 0,026). Ölen hastalarda bu değerlerle beraber enfeksiyonve ek hastalıklar önemli bir etkendi. Enfeksiyonlar arasında sepsis ve pnömoniye rastlanmaktaydı. Hastaların HDL kolesterol değerleri arasında fark saptanmamıştır (p = 0,52).Sonuç: ABH hastalarında enflamasyon, malnütrisyon, sepsis yüksek oranda görülmektedir. ABH da ölen hastalarda (% 4,94) CRP, PCT, SAA, albümin, kolesterol değerleri yüksek saptanmış olup bu değerler tedavi ve izlemde önemini korumaktadır.

Premise Factors of Mortality in Acute Kidney Injury

Objective: Procalcitonin (PCT), C-Reactive Protein, serum amyloid A (SAA) and serum cholesterol values areearly markers for inflammation, infection and malnutrition. In development acute kidney injury (AKI) infection,oral intake disorders, dehydratation and malnutritionhave important place. These factors are important in theearly detection of treatment.Material and Methods: Between January 2013-2014 inour nephrology clinic followed 182 patients and diagnosed AKI with RIFLE (risk, injury, failure, loss, end stagerenal failure) and AKIN (acute kidney injury network) criterias. Patients were compared according to nutritionaland inflammatory markers with healthy control group(52 patients).Results: Albumin, CRP, procalcitonin and SAA values inAKI patients favor compared with healthy control groupand results were statistically significant (p <0.001 and p= 0.002). Again, leukocytes, cholesterol, LDL cholesterol,triglyceride levels were higher in died AKI patients (p =0.016, p = 0.032, p = 0.03 and p = 0.026) Addition to thesevalues in patients who died, Infection and comorbiditydiseases were important factors. In infections found sepsis and pneumonia. HDL cholesterol levels did not differbetween patients (p = 0.52).Conclusion: Inflammation, malnutrition, sepsis are highly prevalent diseases in AKI patients. Patients who diedin AKI (% 4,94), CRP, PCT, SAA, albumin, and cholesterollevels were higher. Treatment and following these valueswere important.

___

  • Palevsky PM. Epidemiology of acute renal fai- lure: The tip of the iceberg. Clin J Am Soc Nephrol 2006;1(1):6-7.
  • Ympa YP, Sakr Y, Reinhart K, Vincent JL. Has morta- lity from acute renal failure decreased? A systematic review of the literature. Am J Med 2005;118(8):827
  • Macedo E, Bouchard J, Mehta RL. Renal recovery following acute kidney injury. Curr Opin Crit Care 2008;14(6):660-5.
  • Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009;20(1):223-28.
  • Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008;12(47):1-9.
  • Wiedermann CJ, Wiedermann W, Joannidis M. Hy- poalbuminemia and acute kidney injury: A meta-a- nalysis of observational clinical studies. İntensive Care Med 2010;36(10):1657-65.
  • Druml W. Nutritional management of acute renal failure. Am J Kidney Dis 2001;37(1):89-94.
  • Chertow GMAK, Lew NL, Lazarus JM, Lowrie EG. Prealbumin is as important as albümin in the nutri- tional assessment of hemodialysis patients. Kidney İnt 2000;58(6):2512-17.
  • Perez-Valdivieso JR, Bes-Rastrollo M, Mone- dero P, de Irala J, Lavilla FJ. İmpact of prealbumin levels on mortality in patients with acute kidney injury: An observational cohort study. J Ren Nutr 23. Sipe JD, Cohen AS. History of the amyloid fibril. J 2008;18(3):262-8. Struct Biol 2000;130(2-3):88-98
  • Fraunberger P, Nagel D, Walli AK, Seidel D. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med 2000;28(10):3574-5.
  • Pinilla JC, Hayes P, Laverty W, Arnold C, Laxdal V: The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. sky P. Acute renal failure-definition outcome mea- Surgery 1998;124(4):799-805. sures, animal models, fluid therapy and information
  • Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkersfort he diagnosis and risk stratification tiative (ADQI) Group. Crit Care 2004;8(4):204-12. of acute kidney injury: A systematic review. Kidney İnt 2008;73(9):1008-16.
  • Mehta RL, Kellum JA, Shah SV, Molitoris BA, Dirkes S. Sepsis and inflammation: İmpact on acute kidney injury. Nephrol Nurs J 2013;40(2):125
  • Assicot M, Gendrel D, Carsin H, Raymond J, Gu- ilbaud J, Bohuon C. High serum procalcitonin con- centrations in patients with sepsis and infection. 2012;2(1):1-36. Lancet 1993;341(8844):515-8.
  • Becker KL, Snider R, Nylen ES. Procalcitonin as- say in systemic inflammation, infection and sep- sis: Clinical utility and limitations. Crit Care Med 2008;36(3):941-52.
  • Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-re- children. İntensive Care Med 2001;27(1):211-5.
  • Obialo CI, Okonofua EC, Nzerue MC, Tayade AS, Riley LJ. Role of hypoalbuminemia and hypocholes- terolemia as copredictors of mortality in acute renal failure. Kidney İnt 1999;56(3):1058-63.
  • Nie X, Wu B, He Y, Huang X, Dai Z, Miao Q, Song H. Serum procalcitonin predicts development of acute kidney injury in patients with suspected infe- ction. Clin Chem Lab Med 2013;51(8):1655-61.
  • Murugan R, Kellum JA. Acute Kidney İn- jury: What’s the prognosis? Nat Rev Nephrol 2011;7(4):209-17.
  • Ballou SP, Kushner I. C-reactive protein andthea- cutephaseresponse. AdvİnternMed 1992;37(1):313
  • Xie Q, Zhou Y, Xu Z, Yang Y, Kuang D, You H, Ma S. The ratio of CRP to prealbumin levels predict morta- lity in patients with hospital-acquired acute kidney injury. BMC Nephrol 2011;12(30):1-8.
  • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palev- technology needs: The Second İnternational Con- sensus Conference of the Acute Dialysis Quality İni- Ronco C, Warnock DG, Levin A. Acute Kidney İnjury Network: Report of an initiative to improve outco- mes in acute kidney injury. Crit Care 2007;11(2):31.
  • KDIGO Clinical practice guideline for acute kidney injury. Kidney International Supplements